Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
スポンサーリンク
概要
著者
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
Tobinai Kensei
東海大学 医学部
-
SETO Masao
Laboratories of Chemotherapy and Immunology, Aichi Cancer Research Institute
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Takeyama Kunihiko
国立がんセンター中央病院
-
Takeyama Kunihiko
Department Of Hematology/oncology National Cancer Center Hospital
-
Tanimoto Kazuki
国立がんセンター中央病院
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uike Naokuni
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Sakamaki H
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
UEDA Ryuzo
Second Department of Internal Medicine, Medical School Nagoya City University
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
Shimoyama M
Department Of Hematology Anjo Kosei Hospital
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Tamura Kazuo
Division Of Medical Oncology And Hematology Department Of Medicine Fukuoka University Hospital
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Ino T
Fujita Health Univ. School Of Medicine Toyoake City Jpn
-
Ino Teruo
名古屋大学 第1内科
-
Hamajima Nobuyuki
愛知県がんセンター研究所 疫学･予防部
-
Hamajima Nobuyuki
Department Of Preventive Medicine/biostatistics And Medical Decision Making Nagoya University Gradua
-
Seto Masao
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
MIKUNI Chikara
Departments of Internal Medicine Sapporo National Hospital
-
TAKEYAMA Kunihiko
First Department of Internal Medicine, Nagoya University School of Medicine
-
INO Teruo
Department of Internal Medicine, Fujita Health University School of Medicine
-
MIKUNI Chikara
Division of Hematology, Sapporo National Hospital
-
KOBAYASHI Toshitaka
Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
-
MUTO Yoshitomi
Department of Hematology, Toranomon Hospital
-
MASEKI Noboru
Hematology Clinic, Saitama Cancer Center Hospital
-
SAITOH Hidehiko
First Department of Internal Medicine, Nagoya University School of Medicine
-
SHIMOYAMA Masanori
Department of Hematology/Oncology, Nagoya National Hospital
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Seto Masao
Laboratory Of Chemotherapy Aichi Cancer Center Research Institute
-
Mikuni Chikara
Sapporo National Hospital
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Hamajima Nobuyuki
Cancer Information Service And Surveillance Division Cancer For Cancer Control And Information Servi
-
Maseki Noboru
Hematology Clinic Saitama Cancer Center Hospital
-
Muto Yoshitomi
Department Of Hematology Toranomon Hospital
-
Seto Masao
Laboratories Of Chemotherapy And Immunology Aichi Cancer Research Institute
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Takatsuki K
Kumamoto Univ. School Of Medicine Kumamoto Jpn
-
Sano Muneaki
Department Of Surgery Niigata Cancer Center
-
Hamajima Nobuyuki
Division Of Epidemiology Aichi Cancer Center Research Institute
-
Maruta Atsuo
Department Of Hematology Kanagawa Cancer Center
-
Maruta Atsuo
Department Of Hematology/chemotherapy Kanagawa Cancer Center
-
Sakamaki H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Saitoh Hidehiko
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Kobayashi Toshitaka
Division Of Hematology Institute Of Clinical Medicine University Of Tsukuba
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Shimoyama Masanori
Department Of Hematology Anjo Kosei Hospital
-
Hamajima N
Department Of Preventive Medicine Biostatistics And Medical Decision Making Nagoya University Gradua
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Mori Shigeo
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Sakamaki Hisashi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Seto Masao
Department Of Hematology/oncology Nagoya National Hospital
-
Miura Shigeto
Department Of Surgery Aichi Cancer Center
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Progression from myelodysplastic syndrome with monosomy 7 to acute monoblastic leukemia with MLL gene rearrangement
- Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese
- Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARγ gene and colorectal cancer risk in Japanese
- A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population
- Dietary Risk Factors for Colon and Rectal Cancers : A Comparative Case-Control Study
- Effect of dietary antioxidants and risk of oral, pharyngeal and laryngeal squamous cell carcinoma according to smoking and drinking habits
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Comparative Case-referent Study of Risk Factors among Hormone-related Female Cancers in Japan
- Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- An elevation of intracellular calcium and an induction of apoptosis by T-2 toxin in HL-60 cells.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Impact of Established Risk Factors for Breast Cancer in Nulligravid Japanese Women
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Reproducibility of a Short Food Frequency Questionnaire for Japanese General Population
- Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
- Impact of Family History on the Risk of Breast Cancer among the Japanese
- Reduced risk of endometrial cancer from alcohol drinking in Japanese
- One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma : Case-control study
- Dietary patterns and the risk of breast cancer in Japanese women
- Coffee consumption and the risk of endometrial cancer : Evidence from a case-control study of female hormone-related cancers in Japan
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Physical exercise reduces risk of breast cancer in Japanese women
- Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Induction of antitimor cytotoxic activity using CD34^+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells
- Combination of Subareolar Blue Dye and Peritumoral RI for Sentinel Lymph Node Biopsy
- Localization of Gelatinolytic Activity Can Be Detected in Breast Cancer Tissues by Film in situ Zymography
- Limited association between a catechol-O-methyltransferase (CONT) polymorphism and breast cancer risk in Japan
- No Association of the 5' Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
- Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Smoking behavior and attitudes toward smoking cessation among members of the Japanese Cancer Association in 2004 and 2006
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- LONG-TERM FOLLOW UP OF PATIENTS WITH SMALL GASTROINTESTINAL STROMAL TUMORS IN THE STOMACH USING ENDOSCOPIC ULTRASONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION BIOPSY
- Laparoscopic Wedge Resection for Gastrointestinal Stromal Tumors of the Stomach : Initial Experience
- Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling
- Selection of Causal Gene Sets for Lymphoma Prognostication from Expression Profiling and Construction of Prognostic Fuzzy Neural Network Models(MEDICAL BIOTECHNOLOGY)
- Fuzzy Neural Network Applied to Gene Expression Profiling for Predicting the Prognosis of Diffuse Large B-cell Lymphoma
- Reduced Life Expectancy due to Smoking in Large-Scale Cohort Studies in Japan
- TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation
- Monitoring Minimal Residual Disease in Patients With MLL-AF6 Fusion Transcript-Positive Acute Myeloid leukemia Fllowing Allogeneic Bone Marrow Transplantation
- Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria
- Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Thrombopoietin Stimulates Murine Lineage Negative, Scal-1^+, C-Kit^+, CD34^- Cells: Comparative Study With Stem Cell Factor or Interleukin-3
- Inhibitory Effect of AL-3264, a New Antiallergic Agent, on the Prausnitz-Kustner Reaction and Leukotriene Production in Monkeys
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy